OXIS International, Inc. Announces The Introduction Of Breakthrough New Ergothioneine-Based Supplements For Joint Health And Healthy Aging
OXIS INTERNATIONAL, INC. is proud to announce that it will introduce the benefits of Ergothioneine to the consumer market in September 2010 via breakthrough products for joint health and healthy aging. The first products, ErgoFlex® and ErgoPlex®, will initially be marketed via a direct mail offering being developed in partnership with Creative Direct Marketing Group, the leading service provider in the direct mail sector of the direct to consumer channel.
Read the full story here
-
Biologic Joint Repair May Delay Or Prevent The Need For Artificial Knee Joint Replacement says Study
Health Canada approves Bayer’s Xarelto® for market launch
CareFusion Announces National Launch Of Spinal Fracture Device
Canadian scientists make spinal-cord research breakthrough
Fracture Risk Assessment Tool Now Available As An iPhone Application
